• 1. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 2. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 3. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Recent Advances in the Study of Ethyl 2-(Ethylamino)Propanoate (CAS 223128-18-5) in Chemical Biology and Pharmaceutical Research

Ethyl 2-(ethylamino)propanoate (CAS 223128-18-5) is a compound of growing interest in the field of chemical biology and pharmaceutical research. Recent studies have highlighted its potential as a versatile intermediate in the synthesis of bioactive molecules and its role in modulating biological pathways. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its chemical properties, synthetic applications, and pharmacological potential.

One of the key areas of investigation has been the synthesis and optimization of ethyl 2-(ethylamino)propanoate. Researchers have developed novel synthetic routes to improve the yield and purity of this compound, which is critical for its application in drug discovery. For instance, a recent study published in the Journal of Medicinal Chemistry demonstrated an efficient one-pot synthesis method that significantly reduces the production cost and environmental impact. This advancement is particularly relevant for large-scale pharmaceutical manufacturing.

In addition to its synthetic utility, ethyl 2-(ethylamino)propanoate has shown promise as a precursor for the development of new therapeutic agents. A 2023 study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of this compound exhibit notable activity against certain enzyme targets involved in inflammatory diseases. The study utilized molecular docking and in vitro assays to validate the compound's binding affinity and inhibitory effects, suggesting its potential as a lead compound for further drug development.

Another significant finding comes from a recent preprint on bioRxiv, where researchers explored the pharmacokinetic properties of ethyl 2-(ethylamino)propanoate in animal models. The study revealed favorable absorption and distribution profiles, along with a relatively low toxicity profile, making it a candidate for further preclinical evaluation. These findings are particularly encouraging for the development of orally administered drugs.

Despite these promising results, challenges remain in the clinical translation of ethyl 2-(ethylamino)propanoate-based therapeutics. A review article in Current Opinion in Chemical Biology highlighted the need for more comprehensive toxicity studies and formulation optimization to address potential stability issues. Future research directions may include the exploration of prodrug strategies and the development of targeted delivery systems to enhance the compound's efficacy and safety.

In conclusion, ethyl 2-(ethylamino)propanoate (CAS 223128-18-5) represents a valuable scaffold in chemical biology and pharmaceutical research. Its synthetic versatility, biological activity, and favorable pharmacokinetic properties underscore its potential for therapeutic applications. Continued research efforts will be essential to fully realize its clinical potential and address existing challenges.

• 52060-77-2(Methyl 2-(Methylamino)propanoate)
• 132946-21-5(3-Morpholinecarboxylicacid,ethylester,(S)-(9CI))
• 84005-98-1(Ethyl morpholine-3-carboxylate)
• 32418-62-5(Ethyl 2-morpholin-4-ylpropanoate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)